Namocatcat, Mailyn P.
HRN: 23-97-16 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/19/2023
METRONIDAZOLE 500MG (TAB)
12/19/2023
12/25/2023
PO
500mg
TID X 6 Days
S/P Repeat LSTCS
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes